Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022

SELL
$35.2 - $52.6 $482,979 - $721,724
-13,721 Closed
0 $0
Q3 2021

Oct 05, 2021

BUY
$46.35 - $59.75 $54,461 - $70,206
1,175 Added 9.37%
13,721 $670,000
Q2 2021

Jul 30, 2021

BUY
$47.2 - $67.81 $19,116 - $27,463
405 Added 3.34%
12,546 $659,000
Q1 2021

May 11, 2021

BUY
$30.93 - $59.48 $375,521 - $722,146
12,141 New
12,141 $674,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.67B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Hanseatic Management Services Inc Portfolio

Follow Hanseatic Management Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hanseatic Management Services Inc with notifications on news.